Poor Prognoses of Young Hepatocellular Carcinoma Patients with Microvascular Invasion: A Propensity Score Matching Cohort Study

Table 4

Uni- and multivariate analyses of disease-free survival (DFS) and overall survival (OS).

Variable	Number	Univariate		Multivariate
		HR (95% CI)	value	HR (95% CI)	value
DFS
Age, <60/≥60 y	84/84	1.562 (1.119–2.181)	0.009	1.590 (1.135–2.228)	0.007
Postoperative adjuvant TACE, no/yes	102/66	1.652 (1.176–2.320)	0.004	1.647 (1.170–2.320)	0.004
BCLC staging, B-C stage/A stage	137/31	1.293 (1.000–1.671)	0.050	1.288 (0.995–1.667)	0.055
LYM count, ≤1100/>1100/μL	50/118	0.672 (0.507–0.890)	0.006	0.653 (0.484–0.880)	0.005
OS
Age, <60/≥60 y	84/84	1.608 (1.110–2.328)	0.012	1.837 (1.259–2.680)	0.002
Reoperation, no/yes	153/15	2.313 (1.075–4.976)	0.032	1.647 (1.170–2.320)	0.011
GVI, yes/no	49/119	1.795 (1.217–2.648)	0.003	1.293 (0.670–2.494)	0.443
BCLC staging, B-C stage/A stage	137/31	1.543 (1.164–2.045)	0.003	1.349 (0.846–2.151)	0.209
LYM count, ≤1100/>1100/μL	50/118	0.645 (0.467–0.891)	0.008	0.592 (0.419–0.838)	0.003

Abbreviations: HR: hazard ratio; CI: confidence interval.